ZELVYSIA
Live / Applied — Second extension granted (statement of use) (as of 25 Feb 2026)
What this means for you
Not registered yet, but its 03 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98339539
- Mark type
- Stylized text
- Filed
- 03 Jan 2024
- Published for opposition
- 10 Sept 2024
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the prevention and treatment of metabolic diseases and disorders; Pharmaceutical preparations for use in the prevention and treatment of hyperphenylalaninemia and phenylketonuria; Pharmaceutical preparations for use in the treatment and reduction of elevated blood phenylalanine levels in the body
Owner
- Aucta Pharmaceuticals, Inc., Piscataway, NJ, US
- Aucta Pharmaceuticals, Inc., Piscataway, NJ, US
Prosecution history
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Feb 2026 — SOU EXTENSION 2 GRANTED
- 24 Feb 2026 — SOU EXTENSION 2 FILED
- 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Aug 2025 — SOU EXTENSION 1 GRANTED
- 28 Aug 2025 — SOU EXTENSION 1 FILED
- 28 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Jan 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 24 Sept 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 10 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Sept 2024 — PUBLISHED FOR OPPOSITION
- 21 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER